Blogs & News Articles
Oklahoma to Revise Medical Cannabis Statute
According to the bill summary, some of the critical changes HB 2646 would make to the medical cannabis statute are as follows:The State Department of Health (OSDH) would have 90 days to review a grower, processor, or dispensary license application instead of two weeks.The bill would allow an individual to put a medical cannabis dispensary near school properties that are not used for classroom instruction curriculum and are not on the same campus as a building used for such do not constitute a school.In addition to rehabilitation, the bill would allocate 25% of the 7% sales tax to the OSDH from drug and alcohol prevention.The bill would require medical cannabis businesses to submit a certificate of compliance with relevant zoning codes when requesting to change locations.The legislation would no longer require the Oklahoma Medical Marijuana Authority (OMMA) or ODSH to notify a business 24 hours before inspection or investigation.It puts penalties in place for medical cannabis businesses who inaccurately or fraudulently report sales or purchases.Would permit the ODSH to issue a written order to any licensee suspected to violate rules and regulations unless he or she was given a written warning 30 days prior. Unless the licensee requests an administrative hearing within 30 days after receiving the order, the hearing becomes final.Prohibits individuals involved in management operations of a medical cannabis business or facility who had its license revoked, not renewed or surrendered from certain violations from receiving a business, research facility, education facility or waste disposal facility license.Forbid testing laboratories contracted with the OMMA from being owned or employing any individual who has interest in a medical cannabis business or any individual or family member who has a pending licensing application, is a member of the board of directors or is individually financially interested in any medical cannabis license or business.It would no longer require medical cannabis products to have a label indicating the product contains Tetrahydrocannabinol (THC).
A complete list of revisions can be found here.
The legislation will head to the Senate Appropriations Committee next for approval.]]>
© Cannabis Business Times